Научные статьиM.H.Sayidova, S.U.Pulatova2025
QUALITY OF LIFE IMPAIRMENTS IN HUNTINGTON'S DISEASE (LITERATURE REVIEW AND OWN DATA)
Usmanov Firdavs Bakhtiyorovich
Образовательные инновации и интеграция · 102-110 · 1993
Аннотация
Huntington's disease (HD) is a rare, incurable, hereditary neurological disorder that causes the progressive breakdown of nerve cells in the brain. Huntington's chorea is a progressive neurodegenerative hereditary disorder that is transmitted from generation to generation in an autosomal dominant manner. Huntington's chorea occurs in 4-6 cases per 100,000 population (4-6:100,000). The classic symptom is chorea, which is the appearance of hyperkinesis, i.e. uncontrolled movements. This is one of the main features of the disease, which is considered to be the anticipation phenomenon, i.e. the disease progresses gradually and begins at a young age [1]. The mutant huntingtin gene has a repeat of the trinucleotide sequence CAG from 40 to 80. The pathogenesis of HD is multifaceted and involves glutamine aggregation, mitochondrial and oxidative stress, mitochondrial-related pathway dysfunction, and DNA damage. Currently, two drugs, tetrabenazine and deutetrabenazine, are approved for the treatment of HD. Keywords: Huntington's disease, chorea, anticipation phenomenon, dementia, apathy Objective: To analyze a review of the literature on Huntington's disease worldwide and in the Republic of Uzbekistan. The urgency of the problem: Huntington's disease (HD) is a rare congenital neurological disorder characterized by cognitive and psychiatric dysfunction. The current incidence of HD in the United States is 6.52 per 100,000 people. This is higher than the global HD rate [2]. The clinical description of HD was first established in 1872 by the American physician George HD, and in 1993, scientists identified the gene that causes HD (Huntington's Disease Society of America, 2023). This gene is located on chromosome 4 and is responsible for the production of a protein called huntingtin. The normal huntingtin protein plays an important role in axonal transport. The normal huntingtin gene contains a three-base sequence, CAG, repeated 11-29 times. The mutant huntingtin gene contains 40-80 repeats of this CAG sequence. Based on global surveys from 1985 to 2010, the overall new cases of HD were estimated as follows. The overall global prevalence was estimated to be 2.71 per 100,000 population. A survey conducted from 2003 to 2016 showed that the incidence rate of HD in the United States was 6.52 per 100,000 population. The average age of onset of HD is 40 years. If https://scientific-jl.com 9 9 46-son_1-to’plam_Iyun -2025 ISSN:3030-3621 Ta'lim innovatsiyasi va integratsiyasi one of the parents has HD, the probability of their children developing the disease reaches 50%. Patients live an average of 17-20 years after the onset of the disease. The onset and severity of HD development are determined by the number of CAG repeats in the gene [3]. 40 or more trinucleotide CAG repeats are associated with GK. A repeat of 26 or less is considered normal. CAG repeats in the range of 27-39 are considered intermediate. Patients with an intermediate number of repeats may not have the disease. Repeat instability is a condition in which parents, usually fathers, have an intermediate number of CAG repeats compared to those with an intermediate number of CAG repeats. Therefore, intermediate ADHD can occur in children even if it is not present in the parents. Diagnosis of ADHD requires several types of tests. In addition to family and medical history, neurological examinations, neuropsychological tests, psychiatric evaluations, general analyses, brain imaging, and genetic tests are used together to diagnose ADHD[5]. Emotional and psychiatric symptoms. Reflexes, muscle strength, balance, touch, vision, hearing, and mood are also tested. Neuropsychological tests include: standardized tests designed to assess memory, thinking, speaking, reasoning, and mental agility. Psychiatric evaluations include a more in-depth examination of mood, emotions, behavioral patterns, judgment, auditory skills, and disorganized or disorganized thinking. After these tests, the patient is given a magnetic resonance imaging (MRI) or computed tomography (CT) scan to examine the structure and therefore function of the brain. If these tests indicate a diagnosis of HD or if the patient has a family history of HD, the final recommended test is genetic testing. Genetic testing confirms the diagnosis of HD. Although genetic testing is the most accurate way to diagnose HD, the decision to undergo testing is often difficult because of the impact the results may have on one's life. This test analyzes a blood sample to determine the number of CAG repeats in the DNA. Individuals without HD typically have 28 or fewer CAG repeats. Patients with HD have 40 or more repeats. Some people feel that it is better not to know if they have HD because knowing for sure that they have the disease would add to the stress and make the course of the disease more difficult (Stoker et al., 2022) [4]. Patients at risk of developing the disease are tested before having children or starting a new job. In it
Доказательный фрагмент
«Huntington's disease (HD) is a rare, incurable, hereditary neurological disorder that causes the progressive breakdown of nerve cells in the brain.»
Образец извлечения
Демо-превьюHuntington's disease (HD) is a rare, incurable, hereditary neurological disorder that causes the progressive breakdown of nerve cells in the brain. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
- Цитирований
- 0
- Тип
- Журнал
- Страна
- Узбекистан
- Ключевые слова
- Huntington's disease, chorea, anticipation phenomenon, dementia, apathy, Keywords: Huntington's disease
Смежные источники
Общество и инновацииKhosiyat MAMATKULOVA2024
Академические исследования в современной наукеKhudaiberdiyeva Arafat Israilovna, Ph.D Professor hudayberdiyevaarofat@gmail.com +12026
Научные статьиI.B.Yangiboyev, E.X.Berdanov +22025